ceptors, and acute-phase proteins. The mechanism of ac tivation has been well characterized in cell culture systems (Lenardo and Baltimore, 1989; Schreck et aI., 1992; Baeuerle and Henkel, 1994; Sieben list et aI., 1994) . NF-kB is present in the cytoplasm as an inactive multisubunit complex associated with an inhibitory sub unit IkE. Stimulation of the cell induces dissociation of the NF-kB/IkB complex by degrading IkB and allowing the nuclear translocation of free NF-kB. Dissociation of IkB from the heterotrimeric complex involves phosphor ylation of the IkB subunit which is then degraded by the proteasome. In the nucleus, NF-kB binds to a specific DNA motif and regulates transcription of target genes containing NF-kB consensus sequences in their promoter region. Because activation does not require new protein synthesis, it represents an attractive intracellular mecha nism to generate rapid responses.
In the periphery, NF-kB activation has been shown to contribute to immunologically mediated diseases. What role NF-kB plays in the nervous system is not clear. NF-kB in neurons may play a role in synaptic activity (Guerrini et al., 1995; Meberg et ai, 1996) . Furthermore, neuronal NF-kB is developmentally regulated (Bakalkin et al., 1993) . Both neurons and glial cells in vitro can express NF-kB (Sparacio et al., 1992; Moynagh et al., 1993; Rattner et al., 1993; Kaltschmidt et al., 1994a Kaltschmidt et al., ,b, 1995 Guerrini et al., 1995; Carter et al., 1996) . In pri mary cultured neurons derived from embryonic mouse cortex and hippocampus, NF-kB appears to be constitu tively activated (Ka1tschmidt et al., 1994b) . NF-kB has been shown to be activated in multiple types of central nervous system lesions including kainate toxicity (Perez Otano et al., 1996) , convulsant-induced seizures (Prasad et al., 1994) , spinal cord injury (Bethea et al., 1998) , cerebral infarction (Terai et aI., 1996b) , and HIV enceph alopathy (Rattner et al., 1993) as well as in chronic neu rodegenerative conditions such as Alzheimer's disease (Terai et al., 1996a; Kaltschmidt et al., 1997) , multiple sclerosis (Gveric et aI., 1998) , and Parkinson's disease (Hunot et aI., 1997) . NF-kB can be activated by numerous factors, many of which are known to be induced after ischemia reperfusion. These include inflammatory cytokines such as TNFex and IL-l� (Krasnow et aI., 199 1; Moynagh et aI., 1993; Siebenlist et aI., 1994) , hydrogen peroxide/ reactive oxygen species (Schreck et aI., 199 1; Meyer et al., 1993) , increased intracellular calcium (Sen et aI., 1996; Pahl and Baeuerle, 1997) , and glutamate (Kaltschmidt et aI., 1995; Guerrini et aI., 1997) . After experimental myocardial ischemia-reperfusion, NFkB is activated and inhibition of this activation confers protec tion from injury (Morishita et aI., 1997) .
Our previous work demonstrated activation of NF-kB in a rat model of global ischemia (Clemens et aI., 1997) . The present study was undertaken to determine whether NF-kB is activated in rats subjected to focal ischemia reperfusion induced by MCAO. Several time points after reperfusion were evaluated to determine a putative time course of activation. Using a combination of gel shift analysis and immunocytochemistry, we sought to deter mine the identity of the cell type that expressed active NF-kB. Finally, we evaluated the effect of the neuropro tective antioxidant, LY34 1122 [2-(3,5-di-t-butyl-4hydroxypheny 1)-4-(2-(4-meth y lethy laminomethy 1phenyloxy)ethyl)oxazole], on NF-kB activation in this model. Longa et al. (1989) . Before surgery, the animals were housed in groups of 3 to 4 with food and water available ad libitum.
MATERIALS AND METHODS

Focal ischemia-reperfusion
Animal procedures were performed in accordance with the Lilly Research Laboratories animal care and use committee and the guidelines of the National Institutes of Health for the care and use of laboratory animals for experimental procedures.
Body temperature was maintained at 37°C with the use of a homeothermic temperature system (Harvard Apparatus, Hollis ton, MS, U.S.A.). Postsurgery, rats were housed individually.
After the initiation of reperfusion, rats were killed at one of the following time points: 2 hours (n = 8), 6 hours (n = 8), and 12 hours (n = 8). Brain tissue from rats killed at each time point was pooled and processed for electrophoretic mobility gel shift analysis (EMSA) (n = 4 per time point) or processed separately for immunocytochemistry (n = 4).
For MCAO, a 3-0 nylon monofilament suture (Harvard Ap paratus, Holliston, MS, U.S.A.) was prepared by rounding the tip by heating near burning embers, dipping in polY-L-lysine (0.1 % solution, Sigma), and drying in a 60°C oven for I hour before surgery. Anesthesia was induced by inhalation of iso fluorane in Ni02 (70:30). A surgical midline incision was made to expose the left common, external (ECA), and internal carotid arteries. The ECA was tied off permanently and its branches were electrocauterized. Two 5-0 silk sutures were tied loosely around the ECA stump and a microaneurysm clamp was applied to the ECA near its bifurcation with the internal carotid artery. Through a small opening in the ECA the mono filament suture was inserted intraluminally and the silk sutures tightened around the lumen containing the filament. The mi croaneurysm clamp was removed and the suture was gently advanced from the lumen of the ECA into the ICA for a dis tance of 20 mm beyond the bifurcation of the common carotid artery. After the intraluminal suture was placed, the neck inci sion was closed with surgical wound clips. The animals were allowed to awaken from anesthesia and returned to their cages.
Rats that did not demonstrate a right upper extremity paresis and did not exhibit rectal temperature increases of at least 1°C were excluded. After 2 hours of MCAO, rats were reanesthe tized and the monofilament suture slowly withdrawn. The neck incision was closed and the animals allowed free access to food and water until sacrifice.
An additional 5 rats were treated with the antioxidant L Y341 122 [2-(3,5-di-t-butyl-4-hydroxyphenyl)-4-(2-( 4-methy1e thy laminomethyl-phenyloxy )ethy l)oxazole]. Drug treatment was administered by means of a jugular cannula which was inserted before MCAO surgery. L Y341 l22 was prepared by dissolving in physiologic saline (30 mg/mL), soni cating, and adjusting the pH to 6.0. At 1 hour after occlusion of the MCA, a I O-mg/kg intravenous bolus dose was administered slowly over a period of 2 to 5 minutes followed by constant infusion at the same dose. Infusion (0. 1 mLlhour) was carried out for 17 hours at which time the animals were killed and prepared for EMSA. This dosing regime was chosen because Huh et al. (1999) had shown it confers maximal neuroprotec tion (-85% reduction in infarct volume) in this model. The time point for termination of the study was chosen because we were interested in evaluating early events that may be related to ischemiaineuroprotection. As a control, rats (n = 4) were treated under the same conditions with the same volume and infusion rate of saline (pH 6.0). At the termination of the study, rats were rapidly decapitated and the ischemic or the contra lateral striatum and cortex were frozen separately in liquid nitrogen. In these experiments, rats were processed individually for EMSA because previous studies with chemically related antioxidants have shown that individual rats can vary slightly in their response to drug treatment (Clemens et aI., 1998). Immunocytochemistry. Polyclonal antisera generated against specific regions of NF-kB were used for immunocytochemis try. The antisera Ab392 and Ab567 were kindly supplied by Dr.
Warner Greene (Gladstone Institute, UCSF). Ab392 was made against the N-terminal peptide of kBF-I, the p50 homodimer;
Ab567 was raised against the N-terminal peptide of p65. These antibodies are highly specific and have been characterized pre viously (Walker et aI., 1992; DoeITe et aI., 1993) . Monoclonal antibodies directed against specific cellular markers were used. At specific time points after reperfusion, rats for immuno cytochemistry were perfused with phosphate-buffered saline followed by ice-cold periodate lysine paraformaldehyde (2%). 
MAP
Double immunofluorescence. For colocalization experiments
on the same tissue section, double immunofluorescence tech niques were used. Double staining was performed sequentially as follows: sections were stained first with NF-kB p50 antise rum which was localized using biotin antirabbit followed by avidin-Texas red (Vector Labs) and then with one of the mono clonal antibodies: MAP2 for neurons, GFAP for astrocytes, or OX42 for microglia. The monoclonal antibody was localized using goat anti mouse immunoglobulins (high fluorescent con jugate; Antibodies Inc., Davis, CA, U.S.A.). Slides were mounted with fluorescence mounting medium containing DAPI (Vectashield, Vector Labs). Sections were examined using a Nikon Microphot equipped with epifluorescence and Nomar sky optics.
EMSA. For gel shift analysis, animals were rapidly decapi tated at specific time points after reperfusion, and tissue was microdissected on ice. In non treated animals, the cortex and striatum were isolated from each hemisphere and frozen sepa rately in liquid nitrogen. Subsequently, striatum or cortex was pooled from each of the 4 rats killed at each time point and nuclear extracts prepared. For animals treated with L Y341122 or vehicle, each side of the brain including both cortex and striatum was processed separately from each animal. Nuclear 
RESULTS
Occlusion of the middle cerebral artery (MCAO) in rats produces a large focal cerebral infarct that exhibits a well-characterized histopathologic profile (Osborne et aI., 1987; Chiamulera et aI., 1993; Clark et aI., 1993; Zhang et aI., 1994) . At 24 hours after MCAO, a circum scribed region of infarction is observed that is character ized by a central core of necrotic tissue and a peripheral area termed the penumbra that is thought to undergo delayed cell death. There is breakdown of the blood brain barrier and trafficking of peripheral inflammatory cells into the parenchyma (Clark et aI., 1993; Garcia et aI., 1994; Zhang et aI., 1994) . The contralateral side is spared from injury and serves as a useful internal nega tive control. We evaluated NF-kB by immunocytochem istry in the forebrain at early time points after transient MCAO. Nissl staining confirmed the presence of isch emic neurons in the cortex and striatum of rats after transient MCAO (Fig. 1 ). Immunocytochemistry of NF kB produced a distinctive pattern of immunoreactivity confined to the region of infarction at 2, 6, and 12 hours after reperfusion ( Figs. 2 and 3) . Within the infarcted area as well as in the peri infarct region, specific cells expressed specific NF-kB p50 immunoreaction product (Fig. 2) . p65 immunoreactivity revealed a staining pat tern that was very similar to that observed with p50 antiserum (Fig. 3) . Cells scattered throughout the isch emic cortex and striatum expressed p50 and p65 immu noreactivity, and the stain appeared to be distributed in the nucleus of the cell (Figs. 2B, 2D, 3B, and 3D). In the cortex, both pyramidal ( Fig. 3D, ramidal neurons (Fig. 2D , lamina II) expressed p50 and p65 immunoreactivity. The contralateral noninfarcted side showed no detectable immunoreactivity with p50 antiserum ( Figs. 2A and 2C) . A diffuse, cytosolic distri bution of stain was observed in the nonischemic cortex with anti-p65 (Fig. 3C) . The abundance and distribution of staining with both p50 and p65 antibodies did not appear to differ qualitatively when comparing sections from animals evaluated at the different time points postreperfusion. Moreover, the ischemic striatum and the ischemic cortex appeared very similar with respect to the intensity, distribution, and abundance of immunopositive cells. However, quantitative analysis of immunoreactiv ity was not carried out in the present study. The pattern of immunoreactivity appeared to be local ized to the nucleus of presumptive ischemic neurons, the precise domain of activated transcription factors. Double immunofluorescence techniques were used to determine the cell type and precise cellular location of NF-kB im munoreactivity. The DNA fluorescent dye 4', 6diamidino-2-phenylindole was used to label nuclei. The choice of which marker to use for double staining was based on the known expression pattern of markers after focal ischemia. Because ischemic neurons stop express ing markers of neuronal integrity (e.g., MAP-2) very early on after ischemia (Dawson and Hallenbeck, 1996) , colocalization with a neuronal marker was directed at analysis of the periinfarct region. Within the ischemic core, nonneuronal cells predominate, even though astro cytes degenerate in this region as well (Li et aI., 1995) . However, at early time points after ischemia, GFAP im munoreactivity can still be observed. Neurons at the bor- der of the MCA territory were found to coexpress both p50 and MAP 2 ( Figs. 4A and 4B, arrows) . Within the MCA territory, p50 immunoreactivity did not colocalize with the astrocyte marker, OFAP ( Figs. 4D and 4E ), or the microglial marker OX42 (Figs. 40 and 4H) . In all fields, p50 immunot1uorescence was found to colocalize precisely with 4' ,6-diamidino-2-phenylindole-stained nuclei (Figs. 4A, 4C, 4D, 4F, 40, and 41, arrows) . p50 immunoreactive nuclei were approximately 10 ILm and some, particularly in the striatum, showed evidence of compromised integrity, i.e., they appeared shrunken and deformed ( Figs. 4F and 41, arrows) . The morphology and size of immunopositive cells combined with the colocal ization data strongly suggest that NF-kB immunoreac tivity is present in the nuclei of neurons. We then determined NF-kB transcriptional activation in ischemic tissues by EMSA. A low level of constitutive NF-kB activity was found in the nonischemic hemi sphere, suggesting EMSA is a more sensitive measure of transcription factor activation than immunocytochemis try. Increased NF-kB DNA binding activity was ob served in the left ischemic striatum and cortex at 2, 6, and 12 hours after reperfusion (Fig. 5A, lanes A and B) with the most dramatic induction observed at 12 hours postreperfusion. At 6 hours, both ischemic (Figs. 5 and 6H, lanes A and B) and nonischemic hemispheres (Figs. 5 and 6H, lanes C and D) showed elevated NF-kB. Two bands were observed by EMSA. Because our previous studies have shown that the upper band consists of NF kB p65-p50 heterodimers (Clemens et aI., 1997) , this band was used for quantitative densitometry. Quantita tion of the band (Fig. 5A, arrow) showed that there was an approximate 3-fold induction at 2 hours, lA-fold in duction at 6 hours, and 7-fold induction at 12 hours postreperfusion when comparing the ischemic versus nonischemic hemispheres (Fig. SB) . There was no sig nificant difference between the extent of activation in the cortex as compared to that of the striatum at any of the time points evaluated (Figs. SA and SB). The antioxidant, L Y34 1 122, is potently neuroprotec tive in rat models of global as well as focal cerebral ischemia (Clemens et aI., 1999; Huh et aI., 1999) . A structural analog, L Y23 16 17, also neuroprotective (Cle mens et aI., 1993; Block et aI., 1995) , has been shown to attenuate persistent activation of NF-kB in global isch-emia (Clemens et aI., 1997) . To gain insight into the possible function of NF-kB in focal ischemia, we tested the effect of the antioxidant L Y34 1 122 on NF-kB in rats subjected to MCAO. The dosing conditions chosen for these experiments were based on those shown previously to exert the most potent neuroprotection (Huh et aI., \999) . Figures 6A and 6B shows that tissues from ve hicle-treated animals exhibit a significant activation of NF-kB in the ischemic versus contralateral hemisphere. However, tissues from LY34 1 122-treated rats showed a significant reduction in NF-kB DNA-binding activity in the ischemic hemisphere compared with controls ( Fig.  6B) . For optimal dosing conditions and detection of early system. The middle panel shows staining with monoclonal antibody to either MAP-2 (8), GFAP (E), and OX42 (H) labeled with FITC second antibody and the right panel is the nuclear stain 4' ,6-diamidino-2-phenylindole. A to C is the periinfarct cortical region dorsomedial to the infarct. 0 to F and G to I is in the ischemic striatum. (A to C) MAP2 is observed primarily in dendrites but can also be detected in neuronal somata that also have pSO immunoreactivity (arrows). (0 to F) pSO immunoreactivity (D) does not colocalize with GFAP (E) but is present in nuclei of shrunken cell (F, I) presumptive neurons. (E) GFAP staining is present in glial filaments that often juxtapose small cerebral vessels (arrowhead). (G to I) OX42 stains activated microglia (H) that do not colocalize with pSO immunoreactivity (G). Arrows highlight areas of overlap. In panels 0, F, G, and I, nuclei with pSO immunoreactivity show shrunken nuclear morphology. Bar = 10j..l m.
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NF KB is Activated Following
Focal Cerebral Ischemia changes after ischemia-reperfusion, animals in this ex periment were killed at 16 hours after reperfusion. Den sitometric analysis of each band in Fig. 6A shows a statistically significant (P < 0.01) increase in DNA bind ing activity in the ischemic compared to nonischemic hemispheres in the vehicle control group of animals when pooled (Fig. 6B) . In contrast, no significant acti- vation of NF-kB was observed in the ischemic compared to control hemisphere from rats treated with L Y34 1122 (Fig. 6B) . The degree of NF-kB activation in the vehicle treated group of animals varied from animal to animal (Fig. 6A ). This is not unexpected given the observation that normotensive rats subjected to MCAO show a con siderable degree of variation with respect to the size of lesion from animal to animal (Coyle, 1986) . Further more, the extent of reduction in NF-kB-binding activity in drug-treated animals also varied from animal to ani mal. This may be attributable to pharmacodynamic events related to the drug because our previous experi ence in the model of global ischemia showed some de gree of variability in drug efficacy among individual ani mals .
DISCUSSION
We investigated the changes in NF-kB activity during the early hours after transient focal ischemia. This is an important time window because this is the time during which neuronal death takes place. In the present model, 2 hours of MCAO produces a large infarct in the cortex and striatum. Immunocytochemistry of NF-kB p50 and p65 subunits at 2, 6, and 12 hours after reperfusion dem onstrated that NF-kB immunoreactivity was localized to the nuclei of neurons in the ischemic hemisphere. At these time points, NF-kB immunoreactivity was not ob served in other cell types. Importantly, the presence of p50 and p65 in the nucleus corresponded to active NF kB at all the time points because we observed DNA binding activity by gel shift analysis. Electrophoretic mobility gel-shift analysis appears to be a more sensitive index of transcription factor activation compared to im munocytochemistry because constitutively active NF-kB was observed by means of EMSA and not immunocyto chemistry, consistent with our earlier observation in global ischemia . Our results differ from the study of Gabriel et a!. (1999) who observed enhancement of NF-kB binding activity only at 1, 4, and 7 days after the injury, time points during which nuclear p65 immunoreactivity could be observed only in reactive glia. No activation of NF-kB was observed by EMSA at early time points after reperfusion. Furthermore, p65 im munoreactivity was observed in a variety of different cell types including endothelial cells, glia, and some neurons, only some of which exhibited nuclear immunoreactivity. The reasons for the apparent discrepancy are unclear but may be because of technical issues such as the duration of ischemia (1 hour in Gabriel study versus 2 hours in our study), use of different antibodies, or most likely because of the different time points evaluated after ischemia.
EMSA analysis showed a low level of constitutive NF-kB activity in the nonischemic hemisphere which is in agreement with in vitro and in vivo experiments dem onstrating constitutively active NF-kB in neurons (Kaltschmidt et a!., 1994b) . In our study, constitutive NF-kB expression in the nonischemic hemisphere could not be observed as nuclear NF-kB immunoreactivity probably because this level of activation was below the level of detection of the assay. NF-kB DNA binding activity was observed in the ischemic hemisphere at 2 J Cereb Blood Flow Metab, Vol. 20, No. 3, 2000 hours after reperfusion, and this activity intensified at 6 and 12 hours after reperfusion. We also observed an apparent increase in NF-kB DNA-binding activity in the nonischemic hemisphere at 6 hours after occlusion. This may be because the nonischemic hemisphere is exten sively connected to damaged neurons through commis sural pathways. Importantly, NF-kB has been shown to be affected by synaptic activity (Guerrini et a!., 1995; Meberg et a!., 1996) . So the altered synaptic activity caused by the injury might lead to alterations in NF-kB activation in neurons on the contralateral side. Alterna tively, there may be a transient widespread activation of NF-kB at an early time point similar to that observed in global ischemia (Clemens et aI., 1997) .
Our observations that NF-kB is activated after focal cerebral ischemia is consistent with previous studies. However, our observations differ markedly with respect to time course of activation and cell type. Salminen et al (1995) and Gabriel et aI. (1999) detected no increase in NF-kB binding activity during the first 24 hours after ischemia. Both studies observed an increase in activation several days after ischemia likely attributable to infiltra tion of inflammatory cells. Peripheral inflammatory cells as well as glial cells have been shown to possess active NF-kB (Sparacio et aI., 1992; Moynagh et aI., 1993; Rattner et aI., 1993; Baeuerle and Henkel, 1994; Fran kenberger et aI., 1994; Carter et aI., 1996) . Our studies at the early time points after ischemia did not observe NF kB in nonneuronal cells. Thus, at the present time there is no evidence that glia contribute to active NF-kB at early time points after focal stroke. Very early activation of NF-kB was observed by Carroll et al (1998) after 2 hours of MCAO. In that study, the activation of NF-kB increased transiently in the infarcted hemisphere at 15 and 30 minutes after reperfusion. However, by 60 min utes after reperfusion, NF-kB activation returned to base line and remained at this level for the next 120 hours. At present it is unclear why our observations differ from that reported in this study except for possible differences in severity of ischemia, rat strain, and techniques. How ever, our data demonstrating that active NF-kB het erodimers are present in ischemic nuclear extracts as well as neuronal nuclei up to 12 hours after reperfusion provide strong evidence to support a longer lasting acti vation than that reported by Carroll et aI. (1998) because the present data use two different measurements for NF kB activation. Consistent with our observations, activa tion of NF-kB in neurons has recently been reported at 20 hours after reperfusion in mice subjected to transient MCAO (Schneider et aI., 1999) .
The localization of p50 and p65 in the nuclei of neu rons in the present study bears similarities to our previ ous findings in the model of global ischemia where NF kB was localized to nuclei of neurons in the hippocampal CA 1 layer after four-vessel occlusion (Clemens et aI. , 1997) . The time course of cell death in this model differs markedly from that which occurs after global ischemia. In the four-vessel occlusion model, it takes several days for histologic evidence of cell death to occur (Pulsinelli et aI., 1982) whereas after focal stroke neurons begin to degenerate within hours after the insult (Osborne et aI., 1987; Chiamulera et aI., 1993; Clark et aI., 1993; Zhang et aI., 1994) . After four-vessel occlusion, we found that only the neurons that were destined to die had persis tently activated NF-kB. The remainder of the neurons in the brain that survived exhibited transient NF-kB activa tion. In the model of global ischemia, cell death could be blocked by treatment with the antioxidant L Y23 16 17 (Clemens et aI., 1998) , a structural analog of L Y34 1 122. Antioxidant treatment was found to prevent the persis tent rise in NF-kB. However, the transient rise in NF-kB could not be prevented, suggesting that these two rises in NF-kB activation occur by different mechanisms. In the present study using the model of focal stroke, NF-kB activation occurred earlier than that observed after global ischemia likely because of the more rapid time course of cell death. In global ischemia (Clemens et a!., 1998) , as well as in this study, rats treated with the antioxidant did not show significant NF-kB DNA-binding activity. Other studies have shown that the antioxidant L Y34 1122 is neuroprotective in models of global ischemia , traumatic brain injury (Dietrich et aI., 1997) , and focal stroke (Huh et aI., 1999) . Because the above models are all associated with long-lasting increases in NF-kB (Clemens et aI., 1997 , Bethea et aI., 1998 Gabriel et aI., 1999) , the mechanism of neuroprotection of LY34 1122 may be mediated by attenuation of persistent NF-kB activation. In vitro studies support this idea be cause antioxidants that block activation of NF-kB (Schreck et aI., 199 1; Meyer et aI., 1993) can protect neurons against oxidative stress-induced cell death (Behl et aI., 1994; Kaltschmidt et aI., 1997) .
It is interesting that some studies performed in cul tured cells report that NF-kB activation can exert a pro tective effect (Barger et aI., 1995; Beg and Baltimore, 1996; Liu et aI., 1996; Van Antwerp et aI., 1996; Mattson et aI., 1997; Taglialatela et aI., 1997; Lezoua!c'h et aI., 1998; Tamatani et aI., 1999) , but other in vitro studies report that NF-kB activation is necessary for cell death to occur (Lin et a!., 1995; Grilli et aI., 1996; Grimm et aI., 1996) . Few studies have addressed the putative function of NF-kB activation in vivo. Morishita et al. (1997) re ported that inhibition of NF-kB binding decreases dam age from myocardial infarction. Qin et a!. (1998) and Nakai et al. (1999) reported that NF-kB contributes to excitotoxin-induced apoptosis in rat striatum. Phillips et al. (1998) reported that inhibition of NF-kB activation by proteasome inhibition dramatically reduced infarct size after MCAO. Most recently, a study published by Schneider et al. (1999) demonstrated that mice with tar-geted deletion of p50 exhibit reduced infarction when subjected to focal ischemia (Schneider et aI., 1999) . These in vivo studies provide evidence that NF-kB acti vation contributes to neuronal degeneration. Interest ingly, the in vivo conditions where NF-kB seems to con tribute to neuronal cell death seem to be conditions where reactive oxygen species have been proposed to be the initiators of the cascade of events that ultimately results in cell death. Substantial evidence exists for a link between reactive oxygen species, apoptosis, and cell death (Buttke and Sandstrom, 1994; Gorman 1996; Ja cobson et aI., 1996) .
In conclusion, the results of our study demonstrate that NF-kB is progressively activated at 2, 6, and 12 hours after reperfusion in a model of MCAO. The EMSA data which demonstrates active NF-kB heterodimers in nuclear extracts prepared from the ischemic hemisphere support our immunocytochemical data showing localiza tion of p50 and p65 subunits in the nucleus. The cell type which demonstrates nuclear NF-kB subunits is the neu ron. Induction of nuclear p50 and p65 was seen in neu rons confined to the region of ischemia. Double-labeling experiments showed that nuclear NF-kB subunits were present in neurons that exhibited compromised nuclear morphology. Importantly, the antioxidant L Y34 1 122, which has been shown to reduce ischemic neuronal death resulting from global (Clemens et aI., 1993) and focal ischemia (Huh et aI., 1999) , can also reduce the activa tion of NF-kB in this model. This study, in combination with the recent p50 knockout data (Schneider et aI., 1999) , suggests that NF-kB plays a deleterious role in the pathology of cerebral ischemia.
